38 results
DEF 14A
MREO
Mereo Biopharma Group Plc
24 Apr 24
Definitive proxy
7:30am
policy;
approving the design of, and determining the performance measures and targets for the company, and evaluating achievements against those … targets any performance related pay schemes operated by the company and approving the total annual payments made under such schemes;
reviewing the design
10-K
2023 FY
MREO
Mereo Biopharma Group Plc
27 Mar 24
Annual report
5:20pm
by AstraZeneca. There are also a number of other agents in development to other immuno-oncology targets that could compete with an anti-TIGIT approach … program in NSCLC being developed by AstraZeneca. There are also a number of other agents in development to other immuno-oncology targets that could
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
16 Nov 23
Current report (foreign)
7:01am
“targets”, “plans”, “believes”, “expects”, “aims”, “intends”, “will”, “may”, “should”, “anticipates”, “estimates”, “projects” or words or terms of similar
6-K
EX-99.1
MREO
Mereo Biopharma Group Plc
7 Sep 23
Current report (foreign)
7:37am
upon achievement of specified stretching share price performance targets. These awards were valued using a Monte Carlo model with the following key
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
21 Oct 22
Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting
7:06am
by, or that include, the words “targets”, “plans”, “believes”, “expects”, “aims”, “intends”, “will”, “may”, “should”, “anticipates”, “estimates”, “projects
6-K
EX-99.1
2fnb 3o0xg
18 Oct 22
Mereo BioPharma Announces Updated Operating Plan to Maximize Shareholder Value
7:07am
6-K
EX-99.1
zw0un6tfvvlt6t43zft
31 Aug 22
Letter Reiterates Mereo’s Updated Strategic Plan to Maximize Value for All Shareholders and Corrects Rubric’s Assumptions
7:57am
6-K
EX-99.1
aq65vn69kb 77y50o
16 Apr 21
Current report (foreign)
4:10pm
S-8
EX-99.1
b4l09o8abayexo2c109
15 Jan 21
Registration of securities for employees
4:21pm
6-K
EX-99.1
rkozj1df0giqw
14 Jan 21
Current report (foreign)
7:06am
F-1/A
h9p5160ao6x0kruey732
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
F-1/A
9tfefwe0 vtda
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
S-8
EX-99.1
sghxq
18 Feb 20
Registration of securities for employees
5:17pm
S-8
EX-99.1
5zaulv9osgqzu
21 May 19
Registration of securities for employees
1:53pm
20-F
EX-4.7
nzedlky24io 2v4a
29 Apr 19
Annual report (foreign)
4:59pm